tirzepatide

Product

Dual GLP-1/GIP receptor agonist sold as Mounjaro and Zepbound by Eli Lilly

7 stories

Study Finds GLP-1 Weight-Loss Drugs May Cause Less Muscle Loss Than Previously Believed

GLP-1 Drug Users Report Emotional Blunting, Raising 'Ozempic Personality' Concerns

GLP-1 Drugs Show Health Benefits for Patients Who Do Not Lose Weight

Study Links GLP-1 Drug Side Effects to Individual Genetic Variations

AI Analysis of 400,000 Reddit Posts Identifies Previously Overlooked GLP-1 Drug Side Effects

Researchers Identify Genetic Variants That Influence How Well Obesity Drugs Work

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries